Multimodal optical and Gd-based nanoparticles for imaging in inflammatory arthritis

Clinical and Experimental Rheumatology

Volumn 27, Issue 4, 2009, Pages 580-586

  Kim, J S ^a   An, H ^a   Rieter, W J ^a   Esserman, D ^a   Taylor Pashow, K M L ^a   Sartor, R B ^a   Lin, W ^a,a   Tarrant, Teresa K ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Arthritis; Diagnostic imaging; Inflammation; Macrophages; Magnetic resonance imaging; Monocytes; Nanostructures

Indexed keywords

COLLAGEN; GADOLINIUM CHELATE; NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; CONFOCAL MICROSCOPY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; IMMUNOFLUORESCENCE TEST; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SYNOVITIS;

ANIMALS; ARTHRITIS, EXPERIMENTAL; CONTRAST MEDIA; EDEMA; FLUORESCENT ANTIBODY TECHNIQUE; GADOLINIUM; HINDLIMB; INJECTIONS, INTRAVENOUS; MACROPHAGES; MAGNETIC RESONANCE IMAGING; METAL NANOPARTICLES; MICE; MICE, INBRED DBA; MICROSCOPY, CONFOCAL; MONOCYTES; SYNOVITIS;

EID: 70350149409     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. BUDINGER TF, LAUTERBUR PC: Nuclear magnetic resonance technology for medical studies. Science 1984; 226: 288-298 (Pubitemid 14006632)
2. MCQUEEN F, LASSERE M, EDMONDS J et al.: OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging Studies. Summary of OMERACT 6 MR Imaging Module. J Rheumatol 2003; 30: 1387-1392 (Pubitemid 36666374)
3. XIE X, WEBBER CE, ADACHI JD et al.: Quantitative, small bore, 1 Tesla, magnetic resonance imaging of the hands of patients with rheumatoid arthritis. Clin Exp Rheumatol 2008; 26: 860-865
4. BABYN P, DORIA AS: Radiologic investigation of rheumatic diseases. Pediatr Clin N Am 2005; 52: 373-411, vi.
5. LUTZ AM, SEEMAYER C, COROT C et al.: Detection of synovial macrophages in an experimental rabbit model of antigen-induced arthritis: ultrasmall superparamagnetic iron oxide-enhanced MR imaging. Radiology 2004; 233: 149-157
6. LUTZ AM, GOPFERT K, JOCHUM W et al.: USPIO-enhanced MR imaging for visualization of synovial hyperperfusion and detection of synovial macrophages: preliminary results in an experimental model of antigen-induced arthritis. J Magn Reson Imaging 2006; 24: 657-666
7. DARDZINSKI BJ, SCHMITHORST VJ, HOLLAND SK et al.: MR imaging of murine arthritis using ultrasmall superparamagnetic iron oxide particles. Magn Reson Imaging 2001; 19: 1209-1216 (Pubitemid 34016586)
8. TURVEY SE, SWART E, DENIS MC et al.: Noninvasive imaging of pancreatic inflammation and its reversal in type 1 diabetes. J Clin Invest 2005; 115: 2454-2461
9. DENIS MC, MAHMOOD U, BENOIST C et al.: Imaging inflammation of the pancreatic islets in type 1 diabetes. Proc Natl Acad Sci U S A 2004; 101: 12634-12639 (Pubitemid 39122075)
10. WEISSLEDER R, MOORE A, MAHMOOD U et al.: In vivo magnetic resonance imaging of transgene expression. Nat Med 2000; 6: 351-355
11. MOORE A, MARECOS E, BOGDANOV A et al.: Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model. Radiology 2000; 214: 568-574
12. HARISINGHANI MG, BARENTSZ J, HAHN PF et al.: Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 2003; 348: 2491-2499
13. JAFFER FA, NAHRENDORF M, SOSNOVIK D et al.: Cellular imaging of inflammation in atherosclerosis using magnetofluorescent nanomaterials. Mol Imaging 2006; 5: 85-92.
14. WU YL, YE Q, FOLEY LM et al.: In situ labeling of immune cells with iron oxide particles: an approach to detect organ rejection by cellular MRI. Proc Natl Acad Sci U S A 2006; 103: 1852-1857
15. LANZA GM, WINTER PM, CARUTHERS SD et al.: Nanomedicine opportunities for cardiovascular disease with perfluorocarbon nanoparticles. Nanomed 2006; 1: 321-329
16. VAN DER HEIJDE DM, VAN 'T HOF M, VAN RIEL PL et al.: Development of a disease activity score based on judgment in clinical practice by rheumatologists. J Rheumatol 1993; 20: 579-581
17. CIMMINO MA, INNOCENTI S, LIVRONE F et al.: Dynamic gadolinium-enhanced magnetic resonance imaging of the wrist in patients with rheumatoid arthritis can discriminate active from inactive disease. Arthritis Rheum 2003; 48: 1207-1213
18. OSTERGAARD M, LORENZEN I, HENRIKSEN O: Dynamic gadolinium-enhanced MR imaging in active and inactive immunoinflammatory gonarthritis. Acta Radiol 1994; 35: 275-81.
19. OLIVER C, SPEAKE S, WATT I et al.: Advantages of an increased dose of MRI contrast agent for enhancing inflammatory synovium. Clin Radiol 1996; 51: 487-493 (Pubitemid 126690541)
20. RIETER WJ, KIM JS, TAYLOR KM et al.: Hybrid silica nanoparticles for multimodal imaging. Angew Chem Int Ed 2007; 46: 3680-3682
21. DE RYCKE L, BAETEN D, FOELL D et al.: Differential expression and response to anti-TNFalpha treatment of infiltrating versus resident tissue macrophage subsets in autoimmune arthritis. J Pathol 2005; 206: 17-27.
22. LIBBY P: Inflammation in atherosclerosis. Nature 2002; 420: 868-874
23. SICA A, BRONTE V: Altered macrophage differentiation and immune dysfunction in tumor development. J Clin Invest 2007; 117: 1155-1166
24. TARRANT TK, RAMPERSAD RR, ESSERMAN D et al.: Granulocyte chemotaxis and disease expression are differentially regulated by GRK subtype in an acute inflammatory arthritis model (K/BxN). Clin Immunol 2008; 129: 115-122
25. INGLIS JJ, NOTLEY CA, ESSEX D et al.: Collagen-induced arthritis as a model of hyperalgesia: functional and cellular analysis of the analgesic actions of tumor necrosis factor blockade. Arthritis Rheum 2007; 56: 4015-4023
26. SONG H, QIAO F, ATKINSON C et al.: A complement C3 inhibitor specifically targeted to sites of complement activation effectively ameliorates collagen-induced arthritis in DBA/1J mice. J Immunol 2007; 179: 7860-7867
27. ANDERSSSON-ENGELS S, WILSON BC: In vivo fluorescence in clinical oncology: fundamental and practical issues. J Cell Pharmacol 1992; 3: 48-61.
28. LIPSITZ S.R. LT, IBRAHIM S, LIPSHULTZ S: A partial correlation coefficient and coefficient of determination for multivariate normal repeated measures data. The Statistician 2001; 50: 87-95.
29. HEGEN M, KEITH JC JR, COLLINS M et al.: Utility of animal models for identification of potential therapeutics for rheumatoid arthritis. Ann Rheum Dis 2008; 67: 1505-1515
30. DARDZINSKI BJ, LAOR T, SCHMITHORST VJ et al.: Mapping T2 relaxation time in the pediatric knee: feasibility with a clinical 1.5-T MR imaging system. Radiology 2002; 225: 233-239
31. VAN BREUSEGHEM I, BOSMANS HT, ELST LV et al.: T2 mapping of human femorotibial cartilage with turbo mixed MR imaging at 1.5 T: feasibility. Radiology 2004; 233: 609-614
32. VAN BREUSEGHEM I, PALMIERI F, PEETERS RR et al.: Combined T1-T2 mapping of human femoro-tibial cartilage with turbomixed imaging at 1.5T. J Magn Reson Imaging 2005; 22: 368-372
33. MULHERIN D, FITZGERALD O, BRESNIHAN B: Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. Arthritis Rheum 1996; 39: 115-124 (Pubitemid 26036386)
34. SMITH MD, KRAAN MC, SLAVOTINEK J et al.: Treatment-induced remission in rheumatoid arthritis patients is characterized by a reduction in macrophage content of synovial biopsies. Rheumatology (Oxford) 2001; 40: 367-374